Literature DB >> 11440964

Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma.

E W Tiemersma1, R E Omer, A Bunschoten, P van't Veer, F J Kok, M O Idris, A M Kadaru, S S Fedail, E Kampman.   

Abstract

Exposure to aflatoxins is a risk factor for hepatocellular carcinoma (HCC). Aflatoxins occur in peanut butter and are metabolized by genetically polymorphic enzymes such as glutathione-S-transferases encoded by glutathione-S-transferase mu 1 gene (GSTM1) and glutathione-S-transferase theta 1 gene (GSTT1) and microsomal epoxide hydrolase encoded by epoxide hydrolase gene (EPHX). The rate at which aflatoxins become activated or detoxified may depend on polymorphisms in the encoding genes. GSTM1 homozygous deletion was indeed found to modify the association between peanut butter consumption and HCC. In this study, we investigate possible roles of GSTT1 and EPHX polymorphisms in this relationship. From a Sudanese case-control study on HCC, we analyzed data of 112 incident cases and 194 controls. All participants were interviewed using a standardized questionnaire inquiring about social and demographic factors, peanut butter consumption, and other known HCC risk factors. Univariate analysis showed that GSTT1 polymorphism was not associated with HCC, whereas EPHX 113HH and 139HH genotypes increased the risk of HCC (Odds ratio, 3.10; 95% Confidence interval, 1.18-8.12). Adjustment for age and region of origin slightly attenuated this association (Odds ratio, 2.56; 95% Confidence interval, 0.83-7.95). Interestingly, unlike GSTM1, both GSTT1 and EPHX polymorphism did not modify the association between peanut butter consumption and HCC. In conclusion, these epidemiological findings do not suggest significant roles of GSTT1 and EPHX in aflatoxin metabolism, although EPHX polymorphism is possibly related to the increased risk of HCC. Further studies are needed to investigate mechanisms by which the EPHX polymorphism potentially modifies cancer risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440964

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  21 in total

1.  Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Chen-Yang Duan; Meng-Ying Liu; Shao-bo Li; Kuan-sheng Ma; Ping Bie
Journal:  Tumour Biol       Date:  2013-08-17

2.  Association of the genetic polymorphism of EPHX1 and EPHX2 with the susceptibility to chronic benzene poisoning.

Authors:  Pin Sun; Zhongbin Zhang; Fen Wu; Junxiang Wan; Xibeng Jin; Zhaolin Xia
Journal:  Front Med China       Date:  2007-07

3.  Characterization of liver injury, oval cell proliferation and cholangiocarcinogenesis in glutathione S-transferase A3 knockout mice.

Authors:  Dana R Crawford; Zoran Ilic; Ian Guest; Ginger L Milne; John D Hayes; Stewart Sell
Journal:  Carcinogenesis       Date:  2017-07-01       Impact factor: 4.944

4.  Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk.

Authors:  Ying-Hao Shen; Si Chen; Yuan-Fei Peng; Ying-Hong Shi; Xiao-Wu Huang; Guo-Huan Yang; Zhen-Bin Ding; Yong Yi; Jian Zhou; Shuang-Jian Qiu; Jia Fan; Ning Ren
Journal:  Tumour Biol       Date:  2014-01-08

5.  GSTT1 null genotype contributes to hepatocellular carcinoma risk: a meta-analysis.

Authors:  Ke-Ji Chen; Fei Fan; Yi Wang; Gong-Tian Wei; Lei Hu; Feng Xu
Journal:  Tumour Biol       Date:  2014-01

6.  Possible role of microsomal epoxide hydrolase gene polymorphism as a risk factor for developing insulin resistance and type 2 diabetes mellitus.

Authors:  Maivel H Ghattas; Mahmoud A Amer
Journal:  Endocrine       Date:  2012-05-04       Impact factor: 3.633

7.  Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China.

Authors:  Jian-Hui Zhang; Xia Jin; Yan Li; Rui Wang; Wei Guo; Na Wang; Deng-Gui Wen; Zhi-Feng Chen; Gang Kuang; Li-Zhen Wei; Shi-Jie Wang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 8.  Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.

Authors:  L M Bull; D L White; M Bray; Z Nurgalieva; H B El-Serag
Journal:  Dis Esophagus       Date:  2009-02-13       Impact factor: 3.429

9.  Rainbow trout (Oncorhynchus mykiss) and ultra-low dose cancer studies.

Authors:  David E Williams; Gayle Orner; Kristin D Willard; Susan Tilton; Jerry D Hendricks; Clifford Pereira; Abby D Benninghoff; George S Bailey
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-12-13       Impact factor: 3.228

10.  249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.

Authors:  Jeronimo A Nogueira; Suzane K Ono-Nita; Marcelo E Nita; Marcelo M T de Souza; Eliane P do Carmo; Evandro S Mello; Cristovan Scapulatempo; Denise C Paranaguá-Vezozzo; Flair J Carrilho; Venancio A F Alves
Journal:  BMC Cancer       Date:  2009-06-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.